Hematology Oncology Associates of Illinois - Skokie — Skokie, Illinois

Hematology Oncology Associates of Illinois - Skokie is a clinical research site located in Skokie, Illinois, United States 60076.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Hematology Oncology Associates of Illinois - Skokie has participated in 62 clinical trials with 25 currently active.

Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Associates of Illinois - Skokie?

Hematology Oncology Associates of Illinois - Skokie has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Associates of Illinois - Skokie conducted?

Hematology Oncology Associates of Illinois - Skokie has 62 clinical trials on record, with 25 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Is Hematology Oncology Associates of Illinois - Skokie accredited by Crixeo Health?

Hematology Oncology Associates of Illinois - Skokie has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology Oncology Associates of Illinois - Skokie?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.